X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6157) 6157
Publication (474) 474
Book Review (53) 53
Book Chapter (51) 51
Newsletter (50) 50
Dissertation (10) 10
Conference Proceeding (3) 3
Book / eBook (1) 1
Data Set (1) 1
Government Document (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (3933) 3933
ornithine decarboxylase (2339) 2339
ornithine decarboxylase - metabolism (1727) 1727
humans (1659) 1659
rats (1630) 1630
polyamines (1609) 1609
mice (1494) 1494
biochemistry & molecular biology (1386) 1386
ornithine decarboxylase inhibitors (1353) 1353
male (1297) 1297
female (1093) 1093
polyamines - metabolism (1082) 1082
index medicus (1004) 1004
eflornithine - pharmacology (748) 748
ornithine-decarboxylase (734) 734
oncology (715) 715
cell biology (670) 670
kinetics (554) 554
ornithine decarboxylase - genetics (553) 553
putrescine (535) 535
growth (530) 530
expression (511) 511
cell line (505) 505
cells, cultured (502) 502
enzyme inhibitors (482) 482
ornithine decarboxylase - biosynthesis (476) 476
alpha-difluoromethylornithine (464) 464
metabolism (463) 463
ornithine - analogs & derivatives (440) 440
enzymes (439) 439
physiological aspects (431) 431
cancer (430) 430
cell division - drug effects (429) 429
eflornithine (421) 421
enzyme inhibitors - pharmacology (417) 417
pharmacology & pharmacy (405) 405
ornithine - pharmacology (399) 399
spermidine (387) 387
cells (385) 385
rats, inbred strains (369) 369
putrescine - metabolism (366) 366
apoptosis (365) 365
ornithine (354) 354
time factors (353) 353
polyamine (351) 351
putrescine - pharmacology (350) 350
inhibition (346) 346
proteins (341) 341
dose-response relationship, drug (336) 336
spermidine - metabolism (336) 336
induction (333) 333
gene expression (331) 331
biosynthesis (327) 327
ornithine decarboxylase activity (324) 324
carboxy-lyases - metabolism (319) 319
spermine (319) 319
molecular sequence data (298) 298
tumor cells, cultured (292) 292
neurosciences (280) 280
biophysics (279) 279
research (279) 279
enzyme induction - drug effects (268) 268
liver - enzymology (268) 268
plant sciences (266) 266
life sciences (265) 265
analysis (263) 263
physiology (260) 260
adenosylmethionine decarboxylase - metabolism (255) 255
research article (247) 247
messenger-rna (246) 246
s-adenosylmethionine decarboxylase (244) 244
spermine - metabolism (244) 244
rna, messenger - metabolism (242) 242
amino acid sequence (241) 241
gene-expression (241) 241
polyamines - pharmacology (237) 237
polyamine metabolism (231) 231
arginine (219) 219
protein (218) 218
tetradecanoylphorbol acetate - pharmacology (211) 211
arginine decarboxylase (209) 209
dna - biosynthesis (203) 203
gene (202) 202
rats, sprague-dawley (202) 202
spermidine - pharmacology (201) 201
carboxy-lyases - antagonists & inhibitors (194) 194
biochemistry, general (191) 191
rats, wistar (190) 190
cycloheximide - pharmacology (188) 188
enzyme induction (188) 188
proliferation (188) 188
spermine - pharmacology (188) 188
antineoplastic agents - pharmacology (187) 187
difluoromethylornithine (187) 187
proteins - metabolism (187) 187
rna, messenger - genetics (187) 187
article (183) 183
base sequence (183) 183
cell proliferation (180) 180
in vitro techniques (178) 178
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6180) 6180
Japanese (55) 55
Russian (21) 21
Chinese (13) 13
French (9) 9
German (4) 4
Spanish (4) 4
Polish (2) 2
Dutch (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Aging Cell, ISSN 1474-9718, 04/2014, Volume 13, Issue 2, pp. 303 - 310
Summary Because of its anabolic effects on muscle, testosterone is being explored as a function‐promoting anabolic therapy for functional limitations... 
steroids | aging | anti‐aging | sex hormones | skeletal muscle | sarcopenia | Aging | Sarcopenia | Sex hormones | Anti-aging | Skeletal muscle | Steroids | LEAN BODY-MASS | PHYSICAL PERFORMANCE | BETA SIGNALING PATHWAYS | CELL BIOLOGY | GERIATRICS & GERONTOLOGY | anti-aging | ACTIVIN-A | MUSCLE STRENGTH | DOUBLE-BLIND | OLDER MEN | ELDERLY-MEN | ANDROGEN RECEPTOR MODULATOR | HYPOGONADAL MEN | Ornithine Decarboxylase - metabolism | Oligonucleotide Array Sequence Analysis | Humans | Body Weight - drug effects | Organ Sparing Treatments | Prostate - growth & development | Eflornithine - pharmacology | Male | Muscle, Skeletal - metabolism | Testosterone - pharmacology | Prostate - metabolism | Enzyme Inhibitors - administration & dosage | Prostate - pathology | Anabolic Agents - pharmacology | Muscle, Skeletal - drug effects | Prostate - drug effects | Eflornithine - administration & dosage | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Mice, Transgenic | Signal Transduction - genetics | Recombinant Proteins - pharmacology | Ornithine Decarboxylase Inhibitors | Organ Size - drug effects | Testosterone - administration & dosage | Animals | Anabolic Agents - administration & dosage | Signal Transduction - drug effects | Follistatin - pharmacology | Mice | Muscle, Skeletal - pathology | Testosterone | DNA microarrays | Enzyme inhibitors | RNA | Analysis | Physiological aspects | Muscles | Genetic engineering | Hormones | Polyamines | Gene expression | Rodents | Original
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2018, Volume 13, Issue 12, p. e0209202
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0127246
Background Neuroblastoma (NB) is the most common cancer in infancy and most frequent cause of death from extracranial solid tumors in children. Ornithine... 
DIAMINE EXPORTER | CELLS | MULTIDISCIPLINARY SCIENCES | ALPHA-DIFLUOROMETHYLORNITHINE | DOUBLE-BLIND | N-MYC | C-MYC | EFLORNITHINE COMBINATION THERAPY | ORNITHINE-DECARBOXYLASE GENE | CANCER | ONCOGENE ADDICTION | Ornithine Decarboxylase Inhibitors - pharmacokinetics | Recurrence | Ornithine Decarboxylase - metabolism | Ornithine Decarboxylase Inhibitors - adverse effects | Humans | Neuroblastoma - enzymology | Child, Preschool | Eflornithine - pharmacokinetics | Eflornithine - adverse effects | Eflornithine - pharmacology | Infant | Male | Eflornithine - therapeutic use | Ornithine Decarboxylase Inhibitors - pharmacology | Ornithine Decarboxylase Inhibitors - therapeutic use | Female | Safety | Child | Etoposide - adverse effects | Neuroblastoma - genetics | Etoposide - pharmacology | Etoposide - therapeutic use | Treatment Outcome | Neuroblastoma - urine | Polyamines - metabolism | Phenotype | Polyamines - urine | Neuroblastoma - drug therapy | Adolescent | Difluoromethylornithine | Dosage and administration | Genetic aspects | Research | Neuroblastoma | Single nucleotide polymorphisms | Drug therapy | Polyamines | Health aspects | Therapy | Pediatrics | Transcription factors | Toxicity | Colorectal cancer | Clinical trials | Oncology | Biosynthesis | Single-nucleotide polymorphism | Epidemiology | Cancer therapies | Regulatory approval | Cell growth | Cell cycle | Children | Drug dosages | Significance | Medical research | Enzymes | Statistical analysis | Etoposide | Pharmacology | Ornithine decarboxylase | Gene expression | Addictions | Patients | Survival | Loci | Substrates | Children & youth | Medicine | Disease prevention | Chemotherapy | Gene amplification | Hospitals | Addiction | Alleles | Solid tumors | Pharmacokinetics | Ornithine | Tumors | Eflornithine | Cancer
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 1931-857X, 10/2008, Volume 295, Issue 4, pp. 995 - 1002
Journal Article
Journal Article
Nature Reviews Cancer, ISSN 1474-175X, 10/2004, Volume 4, Issue 10, pp. 781 - 792
The amino-acid-derived polyamines have long been associated with cell growth and cancer, and specific oncogenes and tumour-suppressor genes regulate polyamine... 
COLON-CANCER | BREAST-CANCER | ONCOLOGY | INITIATION-FACTOR 5A | PROSTATE-CANCER | PHASE-I CHEMOPREVENTION | ORNITHINE-DECARBOXYLASE ACTIVITY | FAMILIAL ADENOMATOUS POLYPOSIS | ALPHA-DIFLUOROMETHYLORNITHINE OTOTOXICITY | SACCHAROMYCES-CEREVISIAE | CERVICAL INTRAEPITHELIAL NEOPLASIA | Neoplasms - metabolism | Ornithine Decarboxylase - metabolism | Cyclooxygenase 2 | Humans | Eflornithine - pharmacology | Neoplasms - prevention & control | Antineoplastic Agents - therapeutic use | Eflornithine - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Neoplasms - genetics | Prostaglandin-Endoperoxide Synthases | Drug Design | Antineoplastic Agents - pharmacology | Genes, Tumor Suppressor | Oncogenes | Ornithine Decarboxylase - genetics | Chemoprevention | Enzyme Inhibitors - pharmacology | Colorectal Neoplasms - prevention & control | Enzyme Inhibitors - therapeutic use | Forecasting | Cyclooxygenase Inhibitors - pharmacology | Neoplasms - drug therapy | Polyamines - metabolism | Membrane Proteins | Ornithine Decarboxylase Inhibitors | Cyclooxygenase 2 Inhibitors | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Models, Biological | Cyclooxygenase Inhibitors - therapeutic use | Isoenzymes - antagonists & inhibitors | Causes of | Genetic aspects | Research | Polyamines | Health aspects | Cancer
Journal Article